Genetic Gains? Affymetrix and Illumina (AFFX, ILMN)

"Two of our long-standing buy recommendations are involved in selling products and services for the genetic research market: Affymetrix AFFX and Illumina ILMN," notes biotech and growth stock specialist Nate Pile. The editor of Nate's Notes explains, "In a nutshell, both of these companies have developed technologies that allow researchers to do what is known as 'high-throughput genetic screening'. "And, while the two companies are direct competitors in many of the markets in which they compete, we believe that both stocks should be bought at the current time. Read the rest here.